These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22251838)

  • 21. alpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy.
    Alleva R; Tomasetti M; Sartini D; Emanuelli M; Nasole E; Di Donato F; Borghi B; Santarelli L; Neuzil J
    Mol Med; 2008; 14(3-4):175-83. PubMed ID: 18079998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
    Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
    Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model.
    Lai LH; Fu QH; Liu Y; Jiang K; Guo QM; Chen QY; Yan B; Wang QQ; Shen JG
    Acta Pharmacol Sin; 2012 Apr; 33(4):523-30. PubMed ID: 22388073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combined use of Camellia sinensis and metronomic zoledronate in 4T1 mouse carcinoma against tumor growth and metastasis.
    Luo KW; Yue GG; Ko CH; Gao S; Lee JK; Li G; Fung KP; Leung PC; Lau CB
    Oncol Rep; 2015 Jul; 34(1):477-87. PubMed ID: 25998578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.
    Marshall JC; Collins JW; Nakayama J; Horak CE; Liewehr DJ; Steinberg SM; Albaugh M; Vidal-Vanaclocha F; Palmieri D; Barbier M; Murone M; Steeg PS
    J Natl Cancer Inst; 2012 Sep; 104(17):1306-19. PubMed ID: 22911670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A stable explant culture of HER2/neu invasive carcinoma supported by alpha-Smooth Muscle Actin expressing stromal cells to evaluate therapeutic agents.
    Piechocki MP
    BMC Cancer; 2008 Apr; 8():119. PubMed ID: 18435859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibitory effect of Adp53 and F56 on growth and metastasis of transplantation of the breast tumor in mice].
    Xiao SW; Yan B; Yang JX; Shou CC; Zhang SW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 39(2):171-6. PubMed ID: 17440594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
    Kim EJ; Hong JE; Eom SJ; Lee JY; Park JH
    Breast Cancer Res Treat; 2011 Nov; 130(1):61-71. PubMed ID: 21170677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells.
    Young E; Miele L; Tucker KB; Huang M; Wells J; Gu JW
    Cancer Biol Ther; 2010 Oct; 10(7):703-11. PubMed ID: 20686367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperbaric oxygen reduces tissue hypoxia and hypoxia-inducible factor-1 alpha expression in focal cerebral ischemia.
    Sun L; Marti HH; Veltkamp R
    Stroke; 2008 Mar; 39(3):1000-6. PubMed ID: 18239183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of hyperbaric oxygen treatment on squamous cell cancer growth and tumor hypoxia.
    Schönmeyr BH; Wong AK; Reid VJ; Gewalli F; Mehrara BJ
    Ann Plast Surg; 2008 Jan; 60(1):81-8. PubMed ID: 18281803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.
    Hwang-Verslues WW; Chang PH; Wei PC; Yang CY; Huang CK; Kuo WH; Shew JY; Chang KJ; Lee EY; Lee WH
    Oncogene; 2011 May; 30(21):2463-74. PubMed ID: 21258409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
    Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
    J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitexin, an inhibitor of hypoxia-inducible factor-1α, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma.
    Xie T; Wang JR; Dai CG; Fu XA; Dong J; Huang Q
    Clin Transl Oncol; 2020 Jul; 22(7):1086-1093. PubMed ID: 31677055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Realgar Nanoparticles Inhibit Migration, Invasion and Metastasis in a Mouse Model of Breast Cancer by Suppressing Matrix Metalloproteinases and Angiogenesis.
    Xiaoxia X; Jing S; Dongbin X; Yonggang T; Jingke Z; Yanying Z; Hulai W
    Curr Drug Deliv; 2020; 17(2):148-158. PubMed ID: 31939730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperbaric oxygen inhibits growth but not differentiation of normal and irradiated osteoblasts.
    Wong AK; Schönmeyr BH; Soares MA; Li S; Mehrara BJ
    J Craniofac Surg; 2008 May; 19(3):757-65. PubMed ID: 18520395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
    Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
    Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.